Yen Y, Yang J, Chang J, Tsai S
Int J Mol Sci. 2022; 23(1).
PMID: 35008751
PMC: 8745262.
DOI: 10.3390/ijms23010325.
Cheng Z, Liu G, Huang C, Zhao X
NPJ Genom Med. 2021; 6(1):75.
PMID: 34548487
PMC: 8455684.
DOI: 10.1038/s41525-021-00207-7.
Xia M, Sheng L, Qu W, Xue X, Chen H, Zheng G
World J Surg Oncol. 2021; 19(1):174.
PMID: 34127010
PMC: 8204537.
DOI: 10.1186/s12957-021-02278-3.
Wang T, Li W, Li H, Li W
Saudi J Biol Sci. 2021; 28(3):1561-1568.
PMID: 33732041
PMC: 7938118.
DOI: 10.1016/j.sjbs.2021.01.013.
Wang J, Zhang M, Hu X, She J, Sun R, Qin S
FEBS Open Bio. 2021; 11(7):1814-1826.
PMID: 33605558
PMC: 8255842.
DOI: 10.1002/2211-5463.13125.
Extracellular miRNAs for the Management of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review.
Inokuchi K, Ochiya T, Matsuzaki J
J Clin Med. 2021; 10(1).
PMID: 33396321
PMC: 7795564.
DOI: 10.3390/jcm10010117.
The NF-κB modulated miR-194-5p/IGF1R/PPFIBP axis is crucial for the tumorigenesis of ovarian cancer.
Bai R, Dou K, Wu Y, Ma Y, Sun J
J Cancer. 2020; 11(12):3433-3445.
PMID: 32284739
PMC: 7150469.
DOI: 10.7150/jca.40604.
miR-194 suppresses high glucose-induced non-small cell lung cancer cell progression by targeting NFAT5.
Meng X, Li Z, Zhou S, Xiao S, Yu P
Thorac Cancer. 2019; 10(5):1051-1059.
PMID: 30900402
PMC: 6500961.
DOI: 10.1111/1759-7714.13038.
Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer.
Shekari N, Javadian M, Ghasemi M, Baradaran B, Darabi M, Kazemi T
J Gastrointest Cancer. 2019; 51(1):70-75.
PMID: 30680612
DOI: 10.1007/s12029-019-00205-0.
Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancer.
Peng Y, Zhang X, Lin H, Deng S, Huang Y, Qin Y
Oncol Rep. 2018; 40(6):3323-3334.
PMID: 30542715
PMC: 6196585.
DOI: 10.3892/or.2018.6773.
PM downregulates miR-194-3p and accelerates apoptosis in cigarette-inflamed bronchial epithelium by targeting death-associated protein kinase 1.
Zhou T, Zhong Y, Hu Y, Sun C, Wang Y, Wang G
Int J Chron Obstruct Pulmon Dis. 2018; 13:2339-2349.
PMID: 30122914
PMC: 6078088.
DOI: 10.2147/COPD.S168629.
miR-194 Inhibits Innate Antiviral Immunity by Targeting FGF2 in Influenza H1N1 Virus Infection.
Wang K, Lai C, Gu H, Zhao L, Xia M, Yang P
Front Microbiol. 2017; 8:2187.
PMID: 29163456
PMC: 5674008.
DOI: 10.3389/fmicb.2017.02187.
MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
He S, Liao B, Deng Y, Su C, Tuo J, Liu J
BMC Cancer. 2017; 17(1):673.
PMID: 28978307
PMC: 5628450.
DOI: 10.1186/s12885-017-3650-5.
Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray.
Wang Y
Pathol Oncol Res. 2017; 23(4):785-791.
PMID: 28078605
DOI: 10.1007/s12253-016-0159-1.
MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers.
Li C, Zhang K, Chen J, Chen L, Wang R, Chu X
Oncotarget. 2016; 8(7):12433-12450.
PMID: 27999212
PMC: 5355356.
DOI: 10.18632/oncotarget.14015.
MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12.
Liang T, Li L, Cheng Y, Ren C, Zhang G
Onco Targets Ther. 2016; 9:4307-15.
PMID: 27486333
PMC: 4956060.
DOI: 10.2147/OTT.S90976.
microRNA-208a in an early stage myocardial infarction rat model and the effect on cAMP-PKA signaling pathway.
Feng G, Yan Z, Li C, Hou Y
Mol Med Rep. 2016; 14(2):1631-5.
PMID: 27314868
PMC: 4940055.
DOI: 10.3892/mmr.2016.5402.
MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis.
Wang Y, Zeng J, Pan J, Geng X, Li L, Wu J
Oncotarget. 2016; 7(20):29275-86.
PMID: 27086911
PMC: 5045395.
DOI: 10.18632/oncotarget.8676.
miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y
Oncotarget. 2016; 7(11):13139-52.
PMID: 26909612
PMC: 4914347.
DOI: 10.18632/oncotarget.7545.
MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Nofech-Mozes R, Khella H, Scorilas A, Youssef L, Krylov S, Lianidou E
Cancer Med. 2016; 5(4):656-64.
PMID: 26860079
PMC: 4831284.
DOI: 10.1002/cam4.631.